Effectiveness of a somatostatin analogue in lowering luteinizing hormone and insulin-stimulated secretion in hyperinsulinemic women with polycystic ovary disease

This publication has 19 references indexed in Scilit:

• Long-term naltrexone treatment normalizes the pituitary response to gonadotropin-releasing hormone in polycystic ovarian syndrome
  Fertility and Sterility, 1993
• The Role of Somatostatin in the Regulation of Anterior Pituitary Hormone Secretion and the Use of Its Analogs in the Treatment of Human Pituitary Tumors
  Endocrine Reviews, 1988
• The role of hyperinsulinemia in the pathogenesis of ovarian hyperandrogenism
  Fertility and Sterility, 1988
• Endocrine profile of a long-acting somatostatin derivative SMS 201–995. Study in normal volunteers following subcutaneous administration
  Acta Endocrinologica, 1986
• Inhibition by Somatostatin of LH-RH-Induced LH Release in Normal Menstruating Women
  Gynecologic and Obstetric Investigation, 1986
• Insulin resistance in polycystic ovary syndrome
  American Journal of Obstetrics and Gynecology, 1983
• Classification and Diagnosis of Diabetes Mellitus and Other Categories of Glucose Intolerance
  Diabetes, 1979
• Effects of Somatostatin on the Secretion of Thyrotropin and Prolactin
  Endocrinology, 1974
• Hypothalamic Polypeptide That Inhibits the Secretion of Immunoreactive Pituitary Growth Hormone
  Science, 1973
• Ein neuer Konstitutionsindex
  Klinische Wochenschrift, 1929